Vardenafil hydrochloride (marketed as Levitra) Information
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.
Related Information
- Regulatory History of Verdenafil from Drugs@FDA
- Information for Healthcare Professionals: Sildenafil (marketed as Viagra and Revatio), Vardenafil (marketed as Levitra), Tadalafil (marketed as Cialis)
- FDA Announces Revisions to Labels for Cialis, Levitra and Viagra
- Questions and Answers about Viagra, Levitra, Cialis, and Revatio: Possible Sudden Hearing Loss
Historical Information
- Vardenafil (marketed as Levitra) Healthcare Professional Sheet (7/2005)
- FDA Updates Labeling for Viagra, Cialis and Levitra for Rare Post-Marketing Reports of Eye Problems